Search
-
News
A new imaging approach relying on Cerenkov light could sometimes substitute for PET scans and improve diagnostic services in underserved areas.
… Monday, April 11, 2022 Positron emission tomography (PET) is one of the most widely used diagnostic tools in cancer care. PET scans show the location of a tumor, usually based on increased glucose intake, a hallmark of cancer cells. Despite their effectiveness, PET scans can be hard to access in developing
-
News
Andrew L. Kung, MD, PhD, has been named the new Chairman of the Department of Pediatrics at Memorial Sloan Kettering Cancer Center (MSK). An accomplished physician, researcher, leader, and mentor, Dr. Kung most recently served as the Chief of the Division of Pediatric Hematology, Oncology, and Stem Cell Transplantation at New York-Presbyterian/Morgan Stanley Children’s Hospital and Columbia University Medical Center (CUMC). Dr. Kung formally assumes his new role as Richard J. O’Reilly, MD, steps down as Chairman after more than 30 years.
… Monday, June 20, 2016 Andrew L. Kung, MD, PhD, has been named the new Chairman of the Department of Pediatrics at Memorial Sloan Kettering Cancer Center (MSK). An accomplished physician, researcher, leader, and mentor, Dr. Kung most recently served as the Chief of the Division of Pediatric Hematology
-
News
Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.
… Friday, January 22, 2021 Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments: Craig B. Thompson Named to City and State’s 2021 Health Power 100 List Craig B. Thompson, MD Craig Thompson, MD, President and CEO of MSK, has been named to the 2021 City & State’s
-
News
Pediatric oncologist Scott A. Armstrong has been named the incumbent of the Grayer Family Chair, and stem cell biologist Kitai Kim has been named to a Geoffrey Beene Junior Faculty Chair.
… Thursday, November 1, 2012 Summary Pediatric oncologist Scott A. Armstrong has been named the incumbent of the Grayer Family Chair, and stem cell biologist Kitai Kim has been named to a Geoffrey Beene Junior Faculty Chair. Pediatric oncologist Scott A. Armstrong has been named the incumbent of the Grayer
-
News
Campaign — inspired by Matthew Heineman’s new documentary, ‘American Symphony,’ featuring Jon Batiste and Suleika Jaouad — aims to bridge the blood stem cell and marrow donor gap and give hope to patients in need.
… Wednesday, November 29, 2023 Campaign — Inspired by Matthew Heineman’s New Documentary, ‘American Symphony,’ Featuring Jon Batiste and Suleika Jaouad — Aims To Bridge the Blood Stem Cell and Marrow Donor Gap and Give Hope to Patients in Need Memorial Sloan Kettering Cancer Center (MSK) and NMDP/Be The
-
News
Memorial Sloan Kettering’s Melanoma Disease Management Team understands the importance of helping these patients maximize the opportunities and overcome the challenges that arise in their lives.
… Wednesday, October 12, 2016 By Jennifer L. Hay, PhD In the past several years, the survivorship experiences for patients diagnosed with melanoma have improved dramatically. Starting with the approval of ipilimumab (Yervoy™) in 2011 for the treatment of advanced melanoma, the FDA has approved more than
-
News
Kathryn V. Anderson has been elected a member of the Institute of Medicine of the National Academies.
… Monday, December 1, 2008 Summary Kathryn V. Anderson has been elected a member of the Institute of Medicine of the National Academies. Kathryn V. Anderson has been elected a member of the Institute of Medicine of the National Academies. Dr. Anderson is a highly respected scientist doing innovative work
-
News
Learn about a clinical trial at Memorial Sloan Kettering that gives people with rectal cancer a new option to be treated without radiation. The research shows that a well-known chemotherapy regimen used alone can be just as effective as chemotherapy given with radiation before surgery. The new method may reduce side effects associated with radiation such as loss of fertility and impaired bladder and sexual function.
… Sunday, June 4, 2023 Even a successful treatment can be improved, to give patients more options, including fewer side effects. That is the benefit of an important clinical trial (research study) involving rectal cancer treatment without radiation that was announced in early June at the American Society
-
News
Conozca un ensayo clínico en Memorial Sloan Kettering que ofrece a las personas con cáncer de recto una nueva opción de tratamiento sin radiación. La investigación muestra que un régimen de quimioterapia conocido, usado solo, puede ser tan eficaz como la quimioterapia combinada con radiación antes de la cirugía. El nuevo método puede reducir los efectos secundarios de la radiación, como la pérdida de fertilidad y los problemas en la función de la vejiga y la función sexual.
… Sunday, June 4, 2023 Hasta un tratamiento exitoso se puede mejorar para dar a los pacientes más opciones, incluso menos efectos secundarios. Ese es el beneficio de un importante ensayo clínico (estudio de investigación) que involucra el tratamiento contra el cáncer de recto sin radiación y que se anunció
-
News
Two outstanding graduate students from the Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences (GSK) have been awarded federal funding to pursue promising cancer research.
… Friday, June 28, 2019 Summary Yuchen Xie and Miguel Miranda-Roman, two GSK students, have been awarded prestigious federal funding. Two outstanding graduate students from the Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences (GSK) have been awarded federal funding to pursue promising cancer